Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada

Notification Icon This version of the form is not currently in use and is provided for reference only. Download this version of Form HLTH5493 for the current year.

Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada

Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada is a document used for requesting special authority for the medication Evolocumab in the province of British Columbia, Canada. This form is specifically for patients who require this medication and need to access it through the provincial health care system. The purpose is to ensure that patients who meet specific criteria outlined by the government can receive coverage for Evolocumab under the healthcare plan in British Columbia.

The Form HLTH5493, Special Authority Request for Evolocumab, in British Columbia, Canada, is typically filed by healthcare professionals or physicians on behalf of their patients. It is used to request coverage for Evolocumab, a medication used to treat high cholesterol.

FAQ

Q: What is the Form HLTH5493?A: The Form HLTH5493 is a Special Authority Request form used in British Columbia, Canada.

Q: What is a Special Authority Request?A: A Special Authority Request is a process in British Columbia, Canada, where patients can request coverage for medications that are not automatically covered by the provincial drug plan.

Q: What is Evolocumab?A: Evolocumab is a medication used to lower cholesterol levels in individuals with certain medical conditions.

Q: Who can use the Form HLTH5493?A: The Form HLTH5493 can be used by patients in British Columbia who have been prescribed Evolocumab by their healthcare provider.

Q: How do I fill out the Form HLTH5493?A: The Form HLTH5493 must be filled out by your healthcare provider. They will provide the necessary information and submit the form on your behalf.

Q: What information is required on the Form HLTH5493?A: The Form HLTH5493 requires information such as the patient's personal details, healthcare provider information, diagnosis, and medical history.

Q: What happens after I submit the Form HLTH5493?A: After submitting the Form HLTH5493, the Special Authority office will review the request and determine if coverage for Evolocumab can be granted.

Q: How long does the Special Authority Request process take?A: The processing time for a Special Authority Request can vary. It is best to contact the BC PharmaCare Special Authority office for the most accurate information.

Q: Is there a fee for submitting the Form HLTH5493?A: There is no fee for submitting the Form HLTH5493.

ADVERTISEMENT

Download Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada

4.6 of 5 (9 votes)
  • Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada

    1

  • Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada, Page 2

    2

  • Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada, Page 1
  • Form HLTH5493 Special Authority Request - Evolocumab - British Columbia, Canada, Page 2
Prev 1 2 Next
ADVERTISEMENT

Related Documents